Monica is an AI assistant powered by GPT-4. Register now to receive 100 free GPT Queries, including GPT-4, GPT-3.5,… https://t.co/i7bHhOjHjS
1:18pm June 4th 2023 via Twitter Web App
Wow, now this is what I've been waiting for! https://t.co/1NmX06VPPU
8:45am May 19th 2023 via Twitter Web App
RT @itsPaulAi: ChatGPT just received its biggest update. It's now connected in real time to the Internet. Here are 8 things that were not…
11:34am May 18th 2023 via Twitter Web App
RT @Codie_Sanchez: 7 graphs that will challenge your intuition: 1. The Relative Value of Higher Education https://t.co/FS7r7trWFW
9:44pm May 17th 2023 via Twitter Web App
RT @pitdesi: What Midjourney thinks professors look like, based on their department https://t.co/7lUZkdnuTi https://t.co/NXLFAig8iI
8:16am May 17th 2023 via Twitter Web App
RT @mkt_sentiment: The most profound advice on the purpose of life is from the most unlikely source as well! https://t.co/eeTCpLzRhf
8:26am April 30th 2023 via Twitter Web App
RT @OlinkProteomics: Join representatives from @uk_biobank, Janssen, Biogen, Olink, Weill Cornell Medicine - Qatar & DNAnexus to walk th
9:47am April 21st 2023 via Twitter Web App
Ulrich #AACR23 Session 7: tertiary prevention- biomarkers of relapse Session 8: AI and data science - the brave new… https://t.co/L8sKJq7mKG
7:16pm April 18th 2023 via Twitter Web App
Ulrich #AACR23 Session 4: preclinical/clinical partnerships in research: innovative team science; Session 5: health… https://t.co/Iv73k1kluX
7:15pm April 18th 2023 via Twitter Web App
Ulrich #AACR23 Ideas: Session 1, setting the stage for cancer prevention agenda; Session 2: early detection and ear… https://t.co/BAiAujsbMD
7:14pm April 18th 2023 via Twitter Web App
Cornelia Ulrich (Huntsman Cancer Inst UT) #AACR23 A brave new world of cancer prevention. As part of the population… https://t.co/FZzfqwWza4
7:12pm April 18th 2023 via Twitter Web App
Visvanathan #AACR23 Can it be used for early detection of breast cancer? Have started the effort.
7:10pm April 18th 2023 via Twitter Web App
Visvanathan #AACR23 The assay 'not good enough to disseminate'; had to develop a 5h test, 1 mL blood, POCT. Scalabl… https://t.co/30PuGUjMbo
7:05pm April 18th 2023 via Twitter Web App
Visvanathan #AACR23 TBCRC-005 prospective biomarker trial results: high CMI (cumulative methylation) at week 4 is a… https://t.co/QvQMliOBl4
7:03pm April 18th 2023 via Twitter Web App
Visvanathan #AACR23 Those you can measure, quantify. Development of panel '22 ref https://t.co/slI66n4yV9 Were thes… https://t.co/UMaNl3mlbk
7:02pm April 18th 2023 via Twitter Web App
Visvanathan #AACR23 Potential clinical utility of DNA methyltation across the breast cancer continuum. atypical hyp… https://t.co/MdMerMqZK8
6:59pm April 18th 2023 via Twitter Web App
Town Hall at #AACR biomarkers and early detection tests for cancer prevention: Kala Visvanathan (Johns Hopkins Univ… https://t.co/NvKoA2tkBJ
6:57pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Indirectly target transc factors by the mediators of the enhancer networks, by targeting SWI/SN… https://t.co/PXZwyqytnV
5:50pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Next: targeting transcription factor 'neo-enhanceosome'.
5:47pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Shows AUC of 80.2% in training of the v2 test. PSA is 0.60. n=743, blinded cohort, 18-transcript… https://t.co/wXnbCdoVe9
5:45pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Improved version with 'MPS-50' with an additional 50 transcripts to improve test, to run on a cu… https://t.co/GZc23SoE0k
5:43pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Have dev a multiplexed urine biomarker for clinically sig prostate cancer TMPRSS2:ERG and lncRNA… https://t.co/FJlSajvdUO
5:42pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Char FOXA1 as an early driver of prostate cancer progression '19 Nature https://t.co/xxHPLOIYdk
5:39pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Clinical lessons '15 Cell ref https://t.co/02Mo0mGRBL
5:38pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Overexp of the gene fusion product ERG, induces prostate cancer in aged mice. One of the first t… https://t.co/vRumIV4pEG
5:34pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Found an imbalance in exons in TEMPRESS2 fused to ERG and ETV1; used 5' RACE to discover, FISH t… https://t.co/6wnKTe1zmR
5:29pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Looked for outlier gene exp, and bioinformatics approach led to discovery of gene fusions in pro… https://t.co/02RBEW4fOP
5:28pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Charles Huggins Nobel Prize winner 1966, androgens are important for prostate ca growth. Discove… https://t.co/lbUq6X7xY7
5:27pm April 18th 2023 via Twitter Web App
Chinnaiyan #AACR23 Chr aberrations in cancer - 1900's hypothesized. Since 2000's, recurrent structural aberrations… https://t.co/bZvVsJKP2j
5:25pm April 18th 2023 via Twitter Web App
Arul Chinnaiyan (Univ Michigan MI) #AACR23 Gene Fusions in solid tumors - implications for precision oncology. On t… https://t.co/xknpu9ME5F
5:22pm April 18th 2023 via Twitter Web App
AACR - James S Ewing-Thelma B Dunn Award for Outstanding Achievement in Pathology in Cancer Research #AACR23 Dr. Arul Chinnaiyan
5:21pm April 18th 2023 via Twitter Web App
Rapisarda #AACR23 Q: Both from pt tissue versus PDX, any differences? A: Quite similar, not much variation by seque… https://t.co/nd9Ij3cyix
3:33pm April 18th 2023 via Twitter Web App
Rapisarda #AACR23 Q: Have they been sequenced? A: WES and RNA-Seq. Q: Same media for different organ types? A: Very… https://t.co/dSnxBVZjDf
Rapisarda #AACR23 Cp to NCI-60: shows similarities, difference of colon adenocarcinoma organoids cp to NCI-60 lines… https://t.co/f4v14NODRY
3:31pm April 18th 2023 via Twitter Web App
Rapisarda #AACR23 PDOrgs <100um, 5% Cultrex RGF BME, Type 2, tested against 166 FDA-approved oncology drugs (100 uM… https://t.co/t1WNEYT
3:26pm April 18th 2023 via Twitter Web App
Rapisarda #AACR23 Has rare and recalcitrant tissue-derived organoids. website: https://t.co/UP5wxfLn63 248 public p… https://t.co/WHCM5MROP3
3:23pm April 18th 2023 via Twitter Web App
Annamaria Rapisarda (Frederick Nat'l Lab for Cancer Research MD) #AACR23 Advancing a screening platform with panels… https://t.co/3z1tZpVcxO
3:22pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Q: What kind of timeline for approval? Medicare reimbursement push you? Diaz: "I think they got… https://t.co/ol6vL6tLkB
1:56pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Q: Can you see a pairings of tests? Castle: Could be triage for positive mammography, could be a screen for spiral CT.
1:50pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Diaz 3: A different level of financial commitment and commitment from payors (for these kind of MCEDs)
1:46pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Diaz 2: Often enrichment tests - 20 pack-years, or genetic predisp, or >45 yo, or sexually activ… https://t.co/BbBZFrj
1:45pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Castle: Great value for low-risk people to relax a bit. Diaz: Low risk is difficult to define. L… https://t.co/muU9jTLfmN
1:44pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Q (from Delphi Dx person) Why not single cancer where there may be more benefit? Spec / Sens tur… https://t.co/ESUn1LHWGB
1:39pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Q: is there a middle ground or wait for years? Castle: Say there may be many tests for many diff… https://t.co/NK9rQhlsNI
1:33pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Bradbury: Luis Diaz commented that 'we may be biting off more than we can chew' and the costs an… https://t.co/hxkSX2xxr8
1:27pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Bradbury: Want to collect data in a registry. Wood: The diagnostic workup is complex. Pathfinder… https://t.co/v9IptU9vhq
1:26pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Castle: NCI knows about 25 MCED tests. Must be another 25 academic centers working on it. LDT pa… https://t.co/2fg5I01NWM
1:21pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Castle pt 2: imaging is also uneven - as far as all organs go. Bradbury: Tumor of origin signal:… https://t.co/3m0eweuarj
1:18pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Castle: About SOC, some SOC tests prevent cancers, e.g. colorectal cancer and cervical cancer sc… https://t.co/QYV1ZdXaM1
1:17pm April 18th 2023 via Twitter Web App
MCED Panel #AACR23 Diaz: These are high-risk tests. "It is more like a potential drug." You have to consider the ha… https://t.co/j4zP8MSogJ
1:14pm April 18th 2023 via Twitter Web App
